- Going to BPI West 2017? Don’t miss these great talks and activities!Posted 18 hours ago
- Cool Tool – PRIME-XV® T Cell CDM – First Commercially Available Chemically-defined, Animal-component-free Medium for T Cell CulturePosted 3 days ago
- Increasing Protein Production with Novel Cell-Ess Titer Boost without Affecting the Metabolic ProfilePosted 1 week ago
- Continuous Processing Optimization with Smarter ToolsPosted 1 week ago
- Cool Tool – Generation of Neural Stem Cells from AlphaSTEM Cultured Pluripotent Stem CellsPosted 1 week ago
- Synergizing Transient and Stable Protein Expression for Accelerated Biotherapeutic DevelopmentPosted 2 weeks ago
- Cell Culture Dish Top Ten Ask the Expert Sessions and Podcasts of 2016Posted 2 weeks ago
- A Look at the Current State of Continuous BioprocessingPosted 2 weeks ago
- Cool Tool – Biomek i-Series – Next Generation Automated Workstations Specifically Designed to Meet Evolving WorkflowsPosted 3 weeks ago
- Filling Industry Gaps with Dedicated Cell Therapy Fluid Transfer SetsPosted 3 weeks ago
Media Optimization Can Improve Glycosylation Patterns and Consistency to Impact Protein Efficacy
When producing a biologic therapeutic, protein quality is a key consideration. While manufacturing parameters such as high protein yield, protein solubility and protein stability are important, it is also critical that the biologic exhibits the desired therapeutic activity. Post-translational modifications impact efficacy and pharmacokinetics of the biotherapeutic, where improper glycosylation can result in an ineffective drug. Proteins are commonly post-translationally modified by adding sugar residues in a process called glycosylation. Half of all human proteins are estimated to be glycosylated.
This session is sponsored by Essential Pharmaceuticals
During this Ask the Expert session, we will be discussing factors that impact glycosylation and tools available to improve the glycoform complexity and increase consistency of glycosylation profiles. Essential Pharmaceuticals is addressing these challenges with their Cell-Ess universal titer boost and optimizer. Cell-Ess was used as a feed in a Wave bioreactor, resulting in greater than 25% increase in monoclonal antibody titer, which was similar to the titer increases observed in earlier experiments using shake flasks. In addition to increasing titer, Cell-Ess was shown to significantly increase consistency of glycosylation patterns when used as a feed. Further, Cell-Ess was shown to increase higher order glycoforms measured by increase in galactosylation. These new data suggest supplementing with Cell-Ess as a feed increases protein titer while improving or maintaining quality.
Who should visit?
- Those in process development for bioproduction of proteins in mammalian cells such as CHO cells
- Those in media optimization or yield optimization for scaled bioproduction of proteins
- Department Directors, Program Directors, Project leaders, involved in optimization of large scale bioproduction of proteins.
Types of Questions?
- What factors influence glycosylation patterns?
- What impact does glycosylation have on efficacy?
- What factors influence consistency of glycosylation patterns from run-to-run?
- What are the benefits of the higher order glycoforms?
This Ask the Expert session is sponsored by Essential Pharmaceuticals and is hosted by Dr. Adam Elhofy, Ph.D., CSO. Dr. Elhofy developed the core technology for the Ess line of products and aided in creating patents around novel uses of materials. Dr. Elhofy has over 14 years of scientific research experience in the areas of immunology, neuroscience, and oncology. He was funded by both the National Institutes of Health and the Multiple Sclerosis society as an investigator at Northwestern University Medical School. His doctoral research won him the award of the Top 5 trainee scientists by the American Association of Immunologists. Dr. Elhofy has 15 scientific publications in peer reviewed journals. He has played a variety of roles with start-up biotech companies ranging from Principal Investigator to Director of Corporate Development.
For more information, please see “Cool Tool – Novel universal titer boost and enhancer improves CHO cell protein production in small bioreactors.”
Please take advantage of the opportunity to ask our expert a question and participate in a lively discussion on animal origin free media optimization.
Questions & Answers
I have been seeing articles on the use of supplements, peptones, etc. regulating glycosylation. Do you think it is better to start with a CD media or with a media that already contains some supplements? Why would these supplements be having an impact on glycosylation? Healthier cells?The optimal way to start would be with a CD media and establish a baseline. Once you have a baseline for your system, then CD supplements can be added individually to determine whether the profile changes. If you are not able to change your profile with the CD supplements, then you can move to the […]» Read More
What impact does Cell-Ess have on glycosylation patterns? When added can your product affect fucosylation or galactosylation?As mentioned, the approach with Cell-Ess is to target the physiological make-up of the ER and Golgi to effectively make them work more efficiently and function appropriately. The hypothesis is if you are able to target the membrane constituents of the ER and Golgi, then there would be greater consistency and higher order glycoforms. With […]» Read More
We are trying to match an existing product profile. What tools are available to achieve this goal? What do you think about glycoengineering? Do you think it is better to try and control the glycosylation or engineer it?The term glycoengineering has been changing over time. Glycoengineering was traditionally defined as any tool used to modify or change the glycosylation patterns. There are 4 basic levers to pull to control the addition of glycans. They are (1) the substrate – namely the sugar nucleotide mix and quantity, (2) the enzymes – glycotransferases and […]» Read More
Do you find that glycosylation is an issue mainly in biosimilars? It seems everything I read on this talks about trying to match the profile of an innovator product?Conceptually this questions addresses the issue of targeting a particular glycan profile. It is true that there is a target profile for both innovator biologics and biosimilars. For the biosimilars, the target is clear – it is the glycan profile of the innovator. For the innovator, in the case of antibodies, there may be a […]» Read More
In your description, you mention that Cell-Ess improves the consistency of glycosylation patterns. Have you seen this replicated and what kind of media are you adding your supplement to? I am just wondering about the consistency of the media and whether that would affect your results. ThanksYou ask an interesting question. We did see the same effect of increased consistency in two different media bases when adding Cell-Ess. Interestingly as you imply there were two different glycosylation patterns because the constituents in the base media were different but the increase in consistency of the glycoform patterns within each group remained the […]» Read More